Clinical Trial Update: Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor [Phase 3]

View source ↗

Summary

Phase 3 trial comparing prophylactic versus on-demand Feiba NF in Hemophilia A or B patients with high-titer inhibitors; study completed with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia
• Hemophilia or with Inhibitors

Drugs mentioned

• Feiba NF (factor VIII complex (activated) concentrate)

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Hemophilia A or B With Inhibitors, Hemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2014-03-14